// App-Quantinova.ai

1583 : SRI31215, a novel inhibitor of oncogenic HGF/MET signaling

Researchers

Presenter

  • Benjamin Y. Owusu

Principal Investigators

  • Phanindra K. Venukadasula

  • Robert A. Galemmo

  • Lidija Klampfer

Medical Centers

  • Southern Research Inst., Birmingham, AL.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Extracellular signal-regulated kinase

  • Signal transducer and activator of transcription 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved